chr1-119033196-CG-C
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PVS1_StrongPM2PP5
The NM_015836.4(WARS2):c.797del(p.Pro266ArgfsTer10) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,614,130 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000025 ( 0 hom. )
Consequence
WARS2
NM_015836.4 frameshift
NM_015836.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.30
Genes affected
WARS2 (HGNC:12730): (tryptophanyl tRNA synthetase 2, mitochondrial) Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Two forms of tryptophanyl-tRNA synthetase exist, a cytoplasmic form, named WARS, and a mitochondrial form, named WARS2. This gene encodes the mitochondrial tryptophanyl-tRNA synthetase. Two alternative transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 4 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-119033196-CG-C is Pathogenic according to our data. Variant chr1-119033196-CG-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 440918.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=4, Uncertain_significance=2}. Variant chr1-119033196-CG-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WARS2 | NM_015836.4 | c.797del | p.Pro266ArgfsTer10 | frameshift_variant | 6/6 | ENST00000235521.5 | NP_056651.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WARS2 | ENST00000235521.5 | c.797del | p.Pro266ArgfsTer10 | frameshift_variant | 6/6 | 1 | NM_015836.4 | ENSP00000235521 | P1 | |
WARS2 | ENST00000369426.9 | c.*163del | 3_prime_UTR_variant | 6/6 | 1 | ENSP00000358434 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152258Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
3
AN:
152258
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 250918Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135680
GnomAD3 exomes
AF:
AC:
9
AN:
250918
Hom.:
AF XY:
AC XY:
3
AN XY:
135680
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1461872Hom.: 0 Cov.: 31 AF XY: 0.0000289 AC XY: 21AN XY: 727238
GnomAD4 exome
AF:
AC:
36
AN:
1461872
Hom.:
Cov.:
31
AF XY:
AC XY:
21
AN XY:
727238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152258Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74398
GnomAD4 genome
AF:
AC:
3
AN:
152258
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74398
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:5Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures Pathogenic:2Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Apr 13, 2022 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 10, 2017 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | May 05, 2022 | - - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 21, 2022 | Frameshift variant predicted to result in protein truncation as the last 95 amino acids are replaced with 9 different amino acids, although loss-of-function variants have not been reported downstream of this position in the protein; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 6447871, 17604309, 24639874, 28236339, 28905505, 28650581, 25385316, 25361775, 25130867, 27389904, 10828066, 15779907, 12557294, 2999114, 7219534, 6997870, 6932013, 31628766, 31617452, 31684799, 31282308, 29783990) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 29, 2018 | DNA sequence analysis of the WARS2 gene demonstrated a one base pair deletion in exon 6, c.797del. This deletion is predicted to result in a frameshift and creation of a premature stop codon nine amino acids downstream, p.Pro266Argfs*10. The c.797del has been described at a low population frequency of 0.004% in gnomAD. The second sequence change identified, c.938A>T, occurs in exon 6 and results in an amino acid change, p.Lys313Met. The p.Lys313Met change affects a moderately conserved amino acid residue located in a domain of the WARS2 protein that is known to be functional. This sequence change has been described in the gnomAD database with a low population frequency of 0.02% (dbSNP rs145867327). The c.797del and c.938A>T sequence changes have been reported in the trans state (on different chromosomes) in two affected siblings with WARS2-related phenotypes (Wortmann et al., 2017. Hum Mutat 38: 1786-1795). - |
Parkinsonism-dystonia 3, childhood-onset Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | May 05, 2022 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 15, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at